Follow

Submissions from 2020

PDF

Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation, Guenther Koehne
Full Text Restricted – Available from BHSF IP or login only

PDF

A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers, Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only

Submissions from 2019

PDF

Randomized phase II trial and tumor mutational spectrum analysis from cabozantinib versus chemotherapy in metastatic uveal melanoma (Alliance A091201), Bruno Bastos
Full Text Restricted – Available from BHSF IP or login only

PDF

Complications of Intrathecal Chemotherapy in Adults: Single-Institution Experience in 109 Consecutive Patients, Fernando Vargas Madueno
Open Access

PDF

Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer, Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only

PDF

Type of TP53 mutation influences oncogenic potential and spectrum of associated K-ras mutations in lung-specific transgenic mice, Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only

Submissions from 2018

PDF

How I treat the young patient with multiple myeloma, Claudia Paba Prada
Full Text Restricted – Available from BHSF IP or login only

PDF

Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update, Michael Troner
Full Text Restricted – Available from BHSF IP or login only

PDF

EML4-ALK Rearrangement and Its Therapeutic Implications in Inflammatory Myofibroblastic Tumors, Fernando Vargas Madueno, Edwin Gould, Raul Valor, and Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only

PDF

Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung Cancer, Miguel Villalona Calero
Open Access

PDF

Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC), Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only

PDF

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden, Miguel Villalona Calero and Zuanel Diaz
Open Access

Submissions from 2016

Global Overview of Colorectal Cancer ― Past, Present and Future, Antonio Ucar

PDF

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology, Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only

PDF

Veliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination Repair, Miguel Villalona Calero
Full Text Restricted – Available from BHSF IP or login only